Halaman 3 - Radioterapi Dokter Terbaik - TOP-60 dokter

Sema Yılmaz was born on July 30, 1965. She received her undergraduate degree from Istanbul University Cerrahpaşa Medical Faculty and completed her medical residency training at the Department of Pediatrics at Zeynep Kamil Women's and Children's Health and Diseases Hospital. She also completed her medical subspecialty training in Pediatric Hematology/Oncology at Cukurova University. Her medical residency thesis was titled "The Relationship Between Morning First Urine Density and Nocturnal Enuresis in Children Aged 3-6 Years", and her medical subspecialty thesis was titled "Comparison of Sphingosine 1-phosphate Receptor 4 Gene Expression in Healthy Children and Neuroblastoma Patients". She started her medical career as a general practitioner. After working as a general practitioner for 4 years, she worked as a doctor researcher at Zeynep Kamil Women's and Children's Health and Diseases Training and Research Hospital for 5 years. She then served as a specialist doctor, assistant professor, and associate professor at various institutions. She worked at Houston MD Anderson, North Carolina-UNC, Boston-Harvard University in the USA. Additionally, she conducted research on cell therapies. She received the title of professor in Pediatric Hematology/Oncology at Usak Medical Faculty. She is a member of the Turkish Pediatric Oncology Group, European Association for Cancer Research (EACR), Turkish Medical Association, Turkish National Pediatrics Association, Turkish Pediatrics Association, Pediatrics Specialty Academy Association (PUADER), Turkish Immunology Association, Turkish Hematology Association, and Molecular Oncology Association (MOKAD). She currently serves her patients at Koru Hospital. Her medical interests include:

Cell therapies in childhood cancers

Cancer immunology

Investigation of genetic pathways responsible for cancer and metastasis

Pulmonary microbiota

BAL transplantation

Dr. Viola Fox adalah Kepala Dokter di Klinik Hematologi, Onkologi, dan Kedokteran Paliatif di BKZ Solingen. Klinik ini merupakan pusat kanker interdisipliner yang telah tersertifikasi. Dr. Fox adalah pakar terkemuka dalam terapi obat untuk penyakit tumor di Jerman dan Eropa. Dia memiliki lebih dari 15 tahun pengalaman di bidang ini.

Dia adalah anggota dari German Society of Oncology and Haemato-oncology (GDHO), German Association of Physicians, dan American Association for Cancer Research. Dr. Fox juga aktif dalam penelitian biologi molekuler. Karyanya mendukung kemajuan dalam pengobatan kanker dan diagnostik molekuler.

Bidang keahliannya meliputi kemoterapi, imunoterapi, terapi target, dan terapi radiasi. Dr. Fox dikenal karena metode-metodenya yang inovatif dan komitmen kuatnya terhadap perawatan pasien. Usahanya telah menghasilkan tingkat pemulihan yang tinggi dan pengakuan dari rekan-rekannya.

Profesor Ari Rafael — direktur layanan Onkologi Translasional dan peneliti di departemen penelitian klinis kanker di Pusat Medis Suraski (Ichilov, Tel Aviv). Pasien menghargai pendekatannya yang individual dan perhatian terhadap kebutuhan setiap individu.

Kualifikasi dan nilai bagi pasien:

• Memimpin rumah sakit onkologi siang hari dan mengarahkan proyek-proyek kedokteran genom nasional. Hal ini memastikan akses ke penelitian terkini.

• Bekerja sebagai penyelidik sub-utama dan penyelidik utama dalam banyak uji klinis fase I–III, termasuk suntikan intratumoral mRNA dan obat-obatan virus. Pasien mendapatkan kesempatan untuk berpartisipasi dalam metode pengobatan inovatif.

• Memiliki pengalaman internasional di AS dan Inggris — menjamin penerapan standar dunia dan protokol canggih.

• Anggota organisasi internasional (ESMO, IASLC, ISLB, ISCORT, Asosiasi Medis Israel). Menggunakan standar pengobatan modern dan berpartisipasi dalam penelitian global.

• Secara rutin meningkatkan kualifikasi dan mengikuti pelatihan sesuai standar praktik klinis internasional, termasuk ICH GCP R2, Panduan MOH Israel, serta kursus terbaru tentang persetujuan yang diinformasikan, penanganan efek samping, dan keselamatan pasien.

Pasien menghargai Profesor Rafael atas pilihan rencana pengobatan yang tepat, penerapan inovasi, dan perhatian yang mendetail, yang memberikan rasa percaya dan aman pada setiap tahap terapi.

Pendidikan :

Universitas Istanbul, Fakultas Kedokteran Istanbul, September 2004 – Juli 2010

Universitas Istanbul, Fakultas Kedokteran Istanbul, Departemen Ortopedi, Residen Februari 2011 - April 2011

Universitas Istanbul, Fakultas Kedokteran Istanbul, Departemen Oftalmologi, Residen Agustus 2011 - Maret 2016

Universitas Thomas Jefferson, Wills Eye Institute, Departemen Onkologi Okular, Pengamatan Agustus 2012 - September 2012

Kementerian Kesehatan Turki, Rumah Sakit Negara Hakkari, Klinik Oftalmologi, Dokter Spesialis Mata Juli 2016 – Maret 2018

Universitas Van Yuzuncu Yil, Fakultas Kedokteran, Departemen Oftalmologi, Asisten Profesor, Maret 2018 – Oktober 2021

Universitas Van Yuzuncu Yil, Fakultas Kedokteran, Departemen Oftalmologi, Profesor Madya, Oktober 2021 – Desember 2021

Universitas Istanbul Yeni Yuzyil, Fakultas Kedokteran, Departemen Oftalmologi, Profesor Madya, Januari 2022 – sekarang

Kualifikasi Pendidikan :

1. Penilaian ilmu dasar oftalmologi oleh International Council of Ophthalmology (ICO) lulus pada April 2017

2. Ujian Optik & Refraksi International Council of Ophthalmology (ICO) lulus pada April 2017

3. Ujian Ilmu Klinis dalam Oftalmologi oleh International Council of Ophthalmology (ICO) lulus pada April 2018

4. Menerima beasiswa ICO-STAAR Bedah Tiga Bulan dalam Vitreo-Retina di University of Kansas, Fakultas Kedokteran, Departemen Oftalmologi di Prairie Village, KS, Amerika Serikat di bawah pengawasan Prof. Radwan Aijlan dari 6 April 2020 hingga 5 Juli 2020.

5. Ujian Lanjutan dalam Oftalmologi oleh International Council of Ophthalmology (ICO) lulus pada Juli 2020.

6. United States Medical Licensing Examination (USMLE) Step 1 lulus pada 7 Januari 2021 dengan 221 poin.

7. United States Medical Licensing Examination (USMLE) Step 2 CK lulus pada 25 Agustus 2021 dengan 214 poin.

Presentasi & Poster :

1. Kongres Oftalmologi Nasional ke-47, Efektivitas terapi fotodinamik pada hemangioma koroid sirkumsirkum, Presentasi lisan, Ozer MD, Tuncer S, November 2013, Antalya, Turki.

2. Kongres Oftalmologi Nasional ke-48, Fitur klinis dan hasil pengobatan rhabdomyosarcoma oftalmik primer: Pengalaman pusat tersier, Ozer MD, Ulas MG, Tuncer S, Presentasi lisan, November 2014, Antalya, Turki

3. Pertemuan ISOO 2015, Hasil Jangka Panjang Terapi Kombinasi (Suntikan Perilesional dan Topikal) Interferon Alpha-2b dalam Manajemen Neoplasia Skuamosa Permukaan Mata, Tuncer S, Ozer MD, Presentasi lisan, Juni 2015, Paris, Prancis

4. Kongres Oftalmologi Nasional ke-49. Pola presentasi klinis sindrom Vogt-Koyanagi-Harada pediatrik dan hasil tindak lanjut jangka panjang, Kiragi D, Ozer MD, Lider-Gezer M, Oray M, Tugal-Tutkun I, Presentasi lisan, November 2015, Istanbul, Turki.

5. Kongres Oftalmologi Nasional ke-49, Ketebalan kornea sentral dan dimensi cakram optik pada pasien glaukoma, Bayraktar S, Ozer MD, Izgi B, Poster, November 2015, Istanbul, Turki.

6. Kongres Oftalmologi Nasional ke-49, Analisis lapisan serat saraf retina dan ketebalan koroid pada pasien dengan sklerosis sistemik untuk mengidentifikasi faktor risiko potensial untuk glaukoma tekanan normal, Ceylan E, Ozer MD, Ekinci M, Yilmaz YC, Poster, November 2015, Istanbul, Turki.

7. Kongres Oftalmologi Nasional ke-50, Pengobatan degenerasi makula terkait usia dengan Ranibizumab intravitreal: Pengalaman kehidupan nyata, Cebeci Z, Yilmaz YC, Ozer D, Kir N, Presentasi lisan, November 2016, Antalya, Turki

8. Kongres Oftalmologi Nasional ke-51, Komplikasi jarang terlihat dari operasi katarak: Hematoma Endokapsular, Ozer MD, Batur M, Artuç T, Seven E, Tekin S, Poster, November 2017, Antalya, Turki

9. Kongres Oftalmologi Nasional ke-52, Nanophthalmos dengan Lipatan Makula, Yavuzer B, Batur M, Seven E, Ozer MD, Poster, November 2018, Antalya, Turki

10. Kongres Oftalmologi Nasional ke-52, Fitur Klinis dan Metode Pengobatan Kasus Selulitis Orbital, Mesen S, Tekin S, Batur M, Duzenli U, Seven E, Ozer MD, Poster, November 2018, Antalya, Turki

11. Kongres Oftalmologi Nasional ke-52, Seri Kasus: Luka Bakar Kimia Mata, Tekin S, Artuç T, Batur M, Ozer MD, Poster, November 2018, Antalya, Turki

12. Kongres Oftalmologi Nasional ke-52, Kehilangan Pendengaran Sensorineural yang Mempengaruhi Frekuensi Rendah pada Pasien dengan Pseudoeksfoliasi, Ozer MD, Batur M, Duzenli U, Seven E, Tekin S, Poster, November 2018, Antalya, Turki

13. Kongres Oftalmologi Nasional ke-52, Intubasi tabung silikon oleh stent Ritleng pada anak-anak di atas dua tahun dengan obstruksi saluran nasolakrimal, Ocal H, Seven E, Tekin S, Ozer MD, Batur M, Poster, November 2018, Antalya, Turki

14. Kongres Oftalmologi Nasional ke-52, Tampilan Bintik Merah Ceri di Makula dan Alkaptonuria: Laporan Kasus, Mesen S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turki

15. Kongres Oftalmologi Nasional ke-52, Komplikasi Langka pada Implantasi Deksametason Intravitreal: Migrasi Implan ke Ruang Anterior, Gulbay S, Batur M, Ozer MD, Tekin S, Poster, November 2018, Antalya, Turki

16. Kongres Oftalmologi Nasional ke-52, Efek Tetes Mata Koenzim Q10 pada Penyembuhan Luka Kornea dalam Pengobatan Keratitis Bakteri, Batur M, Seven E, Tekin S, Ozer MD, Presentasi lisan, November 2018, Antalya, Turki

17. Kongres Euretina ke-19, Efek produksi humor aquous yang berkurang pada potensi pertumbuhan bakteri di mata kelinci, Batur M, Ozer M, Tekin S, Presentasi lisan, September 2019, Paris, Prancis

18. Kongres Oftalmologi Nasional ke-53, Evaluasi fitur klinis pasien dengan hifema akibat trauma tumpul, Seven E, Kebapci F, Tekin S, Batur M, Ozer MD, Presentasi lisan, November 2019, Antalya, Turki

19. Kongres Oftalmologi Nasional ke-53, Kepatuhan terhadap terapi tetes mata dan hubungan kepatuhan dengan perkembangan pada pasien glaukoma, Tekin S, Ocal H, Seven E, Batur M, Ozer MD, Poster, November 2019, Antalya, Turki

20. Kongres Oftalmologi Nasional ke-53, Kehilangan penglihatan bilateral mendadak-sementara setelah pelepasan kateter venosa sentral, Altas AS, Batur M, Sayir F, Seven E, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turki

21. Kongres Oftalmologi Nasional ke-53, Evaluasi klinis terapi fotokoagulasi laser Argon pada pasien dengan robekan retina, Ocal H, Seven E, Batur M, Tekin S, Ozer MD, Poster, November 2019, Antalya, Turki

22. Kongres Oftalmologi Nasional ke-53, Kerusakan makula akibat epilasi laser: laporan kasus, Batur M, Ocal H, Ozer MD, Seven E, Tekin S, Poster, November 2019, Antalya, Turki

23. Kongres Oftalmologi Nasional ke-53, Makulopati Fototoksik akibat Penggunaan Berlebihan Inframerah Iluminator Bersama Scope Penglihatan Malam Tangan, Ozer MD, Batur M, Seven E, Tekin S, Savasan M, Poster, November 2019, Antalya, Turki

24. Kongres Oftalmologi Nasional ke-54, Ophthalmoplegia internal setelah infeksi cacar air, Gedik AC, Ozer MD, Poster, November 2020, Virtual, Turki.

Pengalaman Kerja :

1. Studi Tahap II untuk Menganalisis Sarilumab dalam Uveitis Non-Infeksius (SARILNIUSATURN-Sanofi), Peneliti Pendamping (Peneliti Utama: Prof. Dr. Ilknur Tugal-Tutkun)

2. Efikasi Gevokizumab dalam Pengobatan Pasien dengan Uveitis Penyakit Behçet (EYEGUARD-A&C-Servier), Peneliti Pendamping (Peneliti Utama: Prof. Dr. Ilknur Tugal-Tutkun)

3. Studi Acak, Tertutup Ganda, Dikendalikan Plasebo tentang Efikasi Gevokizumab dalam Pengobatan Pasien dengan Uveitis Penyakit Behçet (EYEGUARD-B-Servier), Peneliti Pendamping (Peneliti Utama: Prof. Dr. Ilknur Tugal-Tutkun)

4. Studi 12 bulan, acak, tertutup ganda, dikendalikan semu, multicenter untuk mengevaluasi efikasi dan keamanan injeksi intravitreal ranibizumab 0,5 mg akibat edema makula akibat faktor pertumbuhan endotel vaskular (VEGF) (RFB002-Novartis), Peneliti sub-injeksi (Peneliti Utama: Prof. Dr. Nur Kir)

5. Studi fase III multicenter, acak, tertutup ganda, dikendalikan semu untuk menilai efikasi dan keamanan lampalizumab yang diberikan secara intravitreal kepada pasien dengan atrofi geografis sekunder akibat degenerasi makula terkait usia (GX29176-Roche), Fotografer (Peneliti Utama: Prof. Dr. Nur Kir)

Dipilih sebagai anggota aktif Asosiasi Oftalmologi Turki, Dewan Dokter Muda, 2020 - sekarang

Berspesialisasi dalam hematologi dan onkologi pediatrik, Dr. Yaman menghadirkan keahlian terfokus pada radioterapi untuk pasien muda.

• Bekerja di Rumah Sakit Universitas Medipol Mega
• Berdedikasi pada perawatan onkologi pediatrik
• Berfokus pada radioterapi untuk anak-anak

Academic Education:

• Bachelor of Medicine and Surgery. University of Barcelona.
• Doctor in medicine. University of Barcelona. Extraordinary prize for doctoral thesis.
• Training in translational research thanks to a post-doctoral stay at Memorial Sloan-Kettering Cancer Center (New York, USA).

Professional Experience:

• Medical Oncologist specialized in urological cancer. Her areas of expertise are prostate cancer, kidney, bladder and urinary tract cancer, and testicular cancer.
• She currently works as a Senior Consultant in the Medical Oncology Service of the Hospital Clínic de Barcelona, ​​where she is responsible for urological cancer. 
• At HM Delfos, from Medical Oncology, she is responsible for the care of patients with urological cancer, from a multidisciplinary approach in coordination with the different specialists (urology, radiotherapy, pathology) through joint work and the Tumor Committee. She is also responsible for the introduction of new therapies and the development of clinical trial projects in this area.

Scientific and Teaching Activity:

• Associate Professor of the Faculty of Medicine of the Clinical Hospital. University of Barcelona. 
• Teaching in the subject of Medical Oncology, of the 5th year of the Degree in Medicine and Surgery at the University of Barcelona. She has been the director of several Final Degree projects for medical students in ​​urological cancer.
• Teacher and Director of the subject "Prostate Cancer" of the Master of Biomedicine. University of Barcelona.
• Teacher and Director of the subject "Comprehensive management of the uro-oncological patient", of the Master of Uro-Oncology of Advanced Medical Competences. University of Barcelona. 
• Direction of several doctoral theses on prostate cancer.
• Extensive experience in the training of Residents in Medical Oncology at the Clinical Hospital de Barcelona.
• Extensive teaching experience in scientific courses and symposiums.
• Internship tutor for students of the Master in Art Therapy at Escuela Metáfora. Art therapy in cancer patients at Hospital Clinic.
• Coordinator of Mindfulness training workshops in Oncology.
• Clinical research:   Extensive experience as principal investigator of multiple clinical trials, phase I, II and III, of new therapies in urological cancer.
• Translational research: Researcher at the August Pi i Sunyer Biomedical Research Institute (IDIBAPS). Leader of the Prostate Cancer working group, within the Translational Genomics Laboratory and Targeted Therapy in Solid Tumors. Her fundamental line of research is based on the investigation of resistance mechanisms to prostate cancer treatments and the study of biomarkers that allow progress towards personalized medicine in this disease.
• She has published more than 140 scientific articles in international journals.

Areas of Professional Interest:

• Her interest as a professional is to provide the best care for patients with urological cancer from all areas: the best care on an individual basis and offer them the best available treatment or the possibility of having access to new treatments within clinical trials. 
• In addition, she has a great interest in promoting comprehensive care for patients and their families.

Associate Professor Dr. Emrah Eraslan graduated from Ankara University Faculty of Medicine in 2005. From 2006 to 2011, he worked as a research assistant in the Department of Internal Medicine at Ankara University Faculty of Medicine and became an internal medicine specialist in 2011. Between 2011 and 2013, he worked as an internal medicine specialist and chief physician at Dr. Nafiz Körez Sincan State Hospital and Palu District State Hospital. From 2013 to 2016, he received medical oncology training at Dr. Abdurrahman Yurtaslan Ankara Oncology Education and Research Hospital and worked there until 2021. In 2023, he became an associate professor and contributed to his field with his publications throughout his career. He currently serves his patients at Koru Ankara Hospital. His medical interests include:

Breast Cancer

Prostate Cancer

Lung Cancer

Colorectal Cancer

Stomach Cancer

Ovarian Cancer

Dr. Hilmi Apak is a respected pediatric hematology-oncology specialist with more than 21 years of experience. He is trained in pediatric oncology. Dr. Apak has led advanced treatments, including bone marrow transplantation, leukemia chemotherapy, and CAR T-cell therapy.

He has published 75 international medical articles, showing his strong contribution to pediatric oncology research. Dr. Apak has worked as assistant editor for the Turkish Pediatrics Archives Periodical. He has also held important academic and leadership positions, such as Head of Pediatric Hematology-Oncology at Istanbul University-Cerrahpaşa.

Assoc. Prof. Dr. Oğuzhan BABACAN completed his undergraduate, specialty and sub-specialty education at GATA Military Medical Faculty/Ankara. After becoming a specialist in Pediatrics, he worked in the field of Social Pediatrics for two years, where Healthy Baby Monitoring and vaccine follow-up were carried out. Then, she completed her subspecialty training in Pediatric Hematology and Oncology and continued her studies in the field of pediatric blood and cancer diseases. In addition to the treatment of children suffering from leukemia, lymphoma, solid tumors and other blood diseases, she has been working in the Bone Marrow Transplantation (Transplant) Unit for 13 years in Allogeneic (unrelated and intrafamilial), Autologous (from the patient himself) and Haploidentical (partially HLA compatible) hematopoietic stem cell transplantation. In 2018, he received the title of Associate Professor in the field of Pediatric Hematology and Oncology Science/Art.

MEDICAL AREAS OF INTEREST

Healthy baby follow-up and vaccinations

Lymph node enlargement

Pediatric patients with anemia (anemia)

Leukemia

Lymphoma

Bone Marrow Transplant

ITP

Thalassemias

Hemophiliacs

Solid tumors

Hemangioma

Childhood blood disorders

Children with frequent infections

Fever of unknown origin

Malnutrition in children

Personal information

Title: Professor Doctor

Branch: Radiation Oncology

Work History:

1 GATA Military Medical Faculty

2 Gayrettepe Florence Nightingale Hospital

3 T.R. Demiroğlu Bilim University \ Associate Professor

4 T.R Demiroğlu Bilim University \ Professor

Medical Specialties and Subspecialties:

1 Head and Neck Cancers

2 Radiation Oncology

Priority treatments:

1 Prostate cancer

2 Conformal treatments

Special advanced health technologies:

1 Truebeam Stx Technology

2 Halcyons

Education

1991 - Istanbul University Istanbul Faculty of Medicine

1996 - Istanbul University Cerrahpaşa Faculty of Medicine Radiation

Oncology Specialization Training

2023 – Istanbul Gaziosmanpaşa Taksim Education and Research Hospital – General Surgery Clinic Associate Professor

2013 – Istanbul Gaziosmanpaşa Taksim Education and Research Hospital – General Surgery Clinic Specialist

2008 – 2013 Private Medical Park Fatih Hospital, General Surgery Specialist - Deputy Chief Physician

2005 – 2007 Private Gelişim Hospital – General Surgery Specialist

2003 – 2005 Private Istanbul Şafak Hospital – General Surgery Specialist - Chief Physician

2002 – 2003 ISTANBUL HASEKİ EDUCATION AND RESEARCH HOSPITAL – General Surgery Clinic Assistant Physician

1998 – 2002 Ankara Education and Research Hospital – General Surgery Clinic Assistant Physician

1998 – Health Sciences University – Istanbul Haseki Health Application and Research Center – Medical Specialization

1991 – Gazi University Faculty of Medicine – Bachelor’s Degree

Certificates

IGM Diagnosis, Treatment Workshop, Granulomatous Mastitis, Kocaeli, Certificate, 07.10.2023 (National)

ibreast 51- Free Flap Reconstruction, Breast Cancer Surgery, Online, Certificate, 30.09.2023 – 30.09.2023 (International)

ibreast 50- Triple Negative Breast Cancer, Breast Cancer, Online, Certificate, 02.09.2023 -02.09.2023 (International)

ibreast 49- Implant Based Reconstruction, Breast Cancer, Online, Certificate, 12.08.2023 -12.08.2023 (International)

ibreast 48- DCIS, İbreast 48- DCIS, Online, Certificate, 15.07.2023 -15.07.2023 (International)

ibreast 47- Conference Updates, Breast Cancer, Online, Certificate, 25.06.2023 -25.06.2023 (International)

ibreast 46- Margin Revisited, Breast Cancer, Online, Certificate, 10.06.2023 -10.06.2023 (International)

1. International 4. National Breast Surgery Congress, Breast Surgery, Ürgüp, Certificate, 05.05.2023 – 07.05.2023 (International)

ibreast 44- HER2 Positive Disease, Breast Cancer, Online, Certificate, 29.04.2023 -29.04.2023 (International)

St-Gallen 2023, St-Gallen Congress Summary Meeting, Istanbul, Certificate, 01.04.2023 -01.04.2023 (National)

ibreast 43- Save The Nipple, Breast Cancer, Online, Certificate, 25.03.2023 -25.03.2023 (International)

ibreast 42-Chest Wall Perforator Flap Revisited, Breast Cancer, Online, Certificate, 25.02.2023 -25.02.2023 (International)

ibreast 41- High Risk And B3 Lesions, Breast Diseases, Online, Certificate, 28.01.2023 -28.01.2023 (International)

15. New Approaches in Breast Cancer Education Meeting, Breast Cancer, Istanbul, Certificate, 07.01.2023 – 08.01.2023 (National)

Articles she wrote and took part in;

1.YILDIRIM EMİNE, BEKTAŞ SİBEL, YETİŞ FIRAT, YILDIZ EREN OZAN, ÖZDEMİR MUHAMMED, KOMUT NESLİHAN, ÇALIK MUSTAFA, ER AHMET MUZAFFER. Correlation between breast and axillary pathologic complete response after neoadjuvant chemotherapy in breast cancer. Annali Italiani di Chirurgia, 2023

2.UZUN NEDİM, YILDIRIM EMİNE. Relationship Between Toilet Type and Hemorrhoids. Bezmialem Vakif University, 2022

3.YILDIZ EREN OZAN, YILDIRIM EMİNE, ORHUN ERDOĞAN KIVILCIM, ERYILMAZ İKLİL, YÜNLÜEL EMİR MEHMET, YETİŞ FIRAT, ULUKENT SUAT CAN. The effect of the covid 19 pandemic on the number of patients treated for acute and complex acute appendicitis. Annali Italiani di Chirurgia, 2202

4.YILDIRIM EMİNE, BEKTAŞ SİBEL, ÖZDEMİR MUHAMMED, KARAGÜLLE AHENK, ER AHMET MUZAFFER, UÇAR NEŞE. Upgrade Rates of DCIS, Intraductal Papilloma, and the Other High-risk Breast Lesions. Hamidiye Medical Journal, 2022
 

5.ÖZKAN GÜMÜŞKAYA PERİHAN, ALTUN ÖZGÜR, KARAKÜTÜK YÜZTAŞ NUR, ÖZSOY NESLİHAN, AYDIN TUTAK GÜLTEN, YILDIRIM EMİNE, ADAŞ MİNE, KÜÇÜK MEHMET. COVID-19 Pnömonisi Sonrası AntiHBs Değerlerindeki Değişiklikler. Journal of Contemporary Medicine, 2022;12(4), 

6.KOMUT NESLİHAN, BEKTAŞ SİBEL, YILDIRIM EMİNE. The relationship of tumor budding with GOLPH3 expression and histopathological prognostic parameters in colorectal adenocarcinoma. Annals of Diagnostic Pathology 2022 Jun;58:151933. 

7.KAYADİBİ YASEMİN, UÇAR NEŞE, AKAN YEŞİM NAMDAR, KAYA MEHMET FATİH, YILDIRIM EMİNE, ALADAĞ KURT SEDA, SOYLU BOY FATMA NUR, TAŞKIN FÜSUN, İÇTEN GÜL ESEN. Magnetic resonance imaging findings associated with recurrence in idiopathic granulomatous mastitis. Clinical Imaging, 2022

8.YILDIRIM EMİNE, KEĞİN MURAT, ÖZDEMİR MUHAMMED, BEKTAŞ SİBEL, PELEN ZEKERİYA, ER AHMET MUZAFFER. Neoplasms of theAppendix; Single Institution and Ten-Year Experiences Results. Turkish Journal of Trauma and Emergency Surgery, 2022;28(3), 352-360

9.YILDIRIM EMİNE, YILDIZ EREN OZAN, ERYILMAZ İKLİL, ER AHMET MUZAFFER, BEKTAŞ SİBEL. Comparison of excised breast volume, re-excision rate and margin positivity in breast-conserving surgery in breast cancer patients using and not using neoadjuvant chemotherapy. Journal of Surgery in Medicine,2022;6

10.YILDIRIM EMİNE, BEKTAŞ SİBEL, PELEN ZEKERİYA, YANIK İREM, ER AHMET MUZAFFER, ÇENGEL FERHAT, ÖZKAN GÜMÜŞKAYA PERİHAN. Histopathological, Radiological, and Demographic Factors Predicting the Response to Neoadjuvant Therapy for Rectal Cancer. Journal of Gastrointestinal Cancer, 2022;53(1)

11.KAYADİBİ YASEMİN, KOÇAK BURAK, UÇAR NEŞE, AKAN YEŞİM NAMDAR, YILDIRIM EMİNE, BEKTAŞ SİBEL. MRI Radiomics of Breast Cancer: Machine Learning-Based Prediction of Lymphovascular Invasion Status. Academic Radiology, 2022;29(1), 126-134.

12.YILDIRIM EMİNE, UÇAR NEŞE, YETİŞ FIRAT, KAYADİBİ YASEMİN, BEKTAŞ SİBEL. Diagnostic performance of breast imaging with ultrasonography, magnetic resonance and mammography in the assessment of residual tumor after neoadjuvant chemotherapy in breast cancer patients. Journal of Surgery and Medicine, 2022;6(1), 43-48

13.YILDIRIM EMİNE, BEKTAŞ SİBEL, GÖKTAŞ AYDIN SABİN, ER AHMET MUZAFFER, YANIK İREM, ÖZKAN GÜMÜŞKAYA PERİHAN, YILMAZ BARBAROS UTKU, BİLİCİ AHMET, ÖNCEL MUSTAFA. Factors Predicting Response to Neoadjuvant Chemotherapy in Locally Advanced Gastric Cancer. Journal of Istanbul Faculty of Medicine / İstanbul Tıp Fakültesi Dergisi, 2022;85(1), 41-50. 

14.YILDIRIM EMİNE, Pelen Zekeriya, KEĞİN MURAT, UÇAR NEŞE, KAYADİBİ YASEMİN, GÜNDOĞAR ÖZGECAN. Evaluation of the Reliability of Preoperative Ultrasonography and Ultrasonography-Guided Fine Needle Aspiration Biopsy in Axillary Staging in Patients With Breast Cancer. Journal of Academic Research in Medicine, 2021;11(3), 269-276., 

15. KAYADİBİ YASEMİN, UÇAR NEŞE, KAYA MEHMET FATİH, YILDIRIM EMİNE, BEKTAŞ SİBEL. Characterization of Suspicious Microcalcifications on Mammography Using 2D Shear-Wave Elastography. Ultrasound in Medicine & Biology, 2022;47(9), 2532-2542. 

16.KAYADİBİ YASEMİN, TEKCAN ŞANLI DENİZ ESİN, UÇAR NEŞE, YILDIRIM EMİNE, ŞANLI AHMET NECATİ. Evaluation of the Appearance Characteristics of Suspicious Microcalcifications Detected by Ultrasonography. Journal of Academic Research in Medicine, 2022;11(2), 199-205. 

17.YILDIRIM EMİNE, ÖZER HİLAL, ÖZER İLTER, KOYUNCU ADİL, YILDIRIM TİMUR. The Effects on Bacterial Translocation and Tissue Damage of Selenium Treatment in an Experimental Intestinal Ischaemia-Reperfusion Model. Turkish Journal of Trauma and Emergency Surgery, 2021;27(4), 389-394. 

18.YILDIRIM EMİNE, AKBAŞ PELİN, ORHUN ERDOĞAN KIVILCIM, BEKTAŞ SİBEL, ÖZKAN GÜMÜŞKAYA PERİHAN, ER AHMET MUZAFFER, PALTURA CEKİ. The comparison of the histopathological results of the thyroid fine-needle aspiration biopsies in the 795 patients with thyroidectomy. Diagnostic Cytopathology, 2021

Nichakorn Seehirunwong, M.D.

Radiologist

Graduated (M.D. From)

Doctor of Medicine, Faculty of Medicine, Prince of Songkla University

• Interpreting the results of medical imaging tests.
• Comparing medical image findings with other examinations and tests.
• Consulting with your referring healthcare provider (the provider who ordered the imaging tests) to help choose the proper imaging test and using test results to inform your medical care. Writing reports of results and diagnoses.
• Recommending additional examinations or treatments when necessary.
• Treating diseases by using radiation (radiation oncology) or imaging-guided procedures (interventional radiology). Performing or directing radiology staff to carry out imaging tests.

Certificates

Certificate of Diagnostic Radiology, Faculty of Medicine, Prince of Songkla University

Current Positions

Diagnostic Radiologist at Intrarat Hospital

Education

09 / 2004 – 07 / 2006                Movie Director School, ANT1 Movie School Athens, Greece, Degree “Television Director”, grade point average: B

09 / 2006 – 08 / 2008                Medical School, Semmelweis University Budapest, Hungary, Medical preliminary examination (Physikum), grade point average: A

10 / 2008 – 05 / 2013                Medical School, Albert-Ludwigs-Universität Freiburg, Germany, State examination in medicine, grade point average: A

02/ 2009 – 02/2012                   Institute of Pharamcology and Toxicology I, Albert-Ludwigs-Universität Freiburg, Germany, Doctoral thesis, grade: summa cum laude

05 / 2018                                      Basic and advanced course in German drug law and GCP, Clinical Trials Unit, Medical Center - University of Freiburg

01 / 2019                                      Board certification: Radiotherapy and Radiation Oncology

03 / 2020                                      Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Habilitation (Postdoctoral lecture qualification)

09 / 21 – 08 / 23                         MHBA, Friedrich Alexander University, Nuernberg, Germany

07 / 2022                                      Completion of ISO 9001:2015 training, Nicosia, Cyprus

Professional Career

09 / 2013 – 01 / 2019               Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Residency                                                

07 / 2017 – 07 / 2020               Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Clinician Scientist

Since 06 / 2019                          Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Consultant

01 / 2021 – 12 / 2022                Bertha-Ottenstein programme, Medical Center, University of Freiburg, Germany, Advanced Clinician Scientist

01 / 2021 – 12 / 2021                 Head of the section “Interventional Radiation Oncology”, Medical Center University of Freiburg, Department of Radiation Oncology, Germany

Since 01 / 2022                         Medical Center University of Freiburg, Department of Radiation Oncology, Germany, Prostate cancer research group leader

Since 01 / 2022                          German Medical Institute, Limassol, Cyprus, Vice Medical Director

Professional Memberships and Distinctions

2010           Sanofi-Aventis poster prize, Annual meeting of the German Society of Pharmacology and Toxicology 2010, Mainz, Germany      

2017           Poster prize, Annual meeting of the German Society of Radiation Oncology (DEGRO) 2017, Berlin, Germany

2019           Poster prize, Uro-Oncological Symposium 2019, Magdeburg, Germany

2020           Invited member of the German expert panel for prostate cancer of the German Society of Radiation Oncology (DEGRO)

2020           Herman-Holthusen Award, German Society of Radiation Oncology (DEGRO)

2021           Invited member of the ESTRO-ACROP guideline committee for prostate cancer

2021           Best Abstract, EMUC congress 2021, Athens, Greece

2023           Annual ARO study price for the HypoFocal-SBRT study from the German Cancer Foundation

2023           Invited member of the ESTRO focus group “Urology”

• Education: 
•  
• 2001-2007: University of Ioannina Medical School, Greece.
• 2007: Degree in Medicine.
• 2013: Doctoral degree from the Medical School of the Johann Wolfgang Goethe University, Frankfurt (Dr. Med)
• 09.2016 – Today: Master’s in Healthcare Business Studies.

Professional experience:

04.2009 – 04.2013: Resident in the Department for Radiation Oncology, Klinikum Offenbach

05.2013 – 12. 2015: Senior physician in the Department for Radiation Oncology, Klinikum Offenbach

• 01.2016 – 06.2017: Senior physician in the Department of interventional Radiation Oncology, Medical Center Athens
•  
• 07.2017 – Today: Head of the Department of Radiation Oncology at the German Oncology Center, Limassol, Cyprus.

Doctor Brenda Pastrana is a mexican surgical Oncologist. 

Medical background.

Centro Medico Nacional 20 de Noviembre Issste, Surgical Oncologist in 2020.

Title by Universidad Autónoma de México UNAM.

Surgical Residency Instituto Mexicano del Seguro Social. 2015.

Title by Universidad de Quintana Roo. 

Board Certified by Conacem from 2020 to 2025 number 2171 

Board Certified by Conacem from 2025 to 2030 number 2171

Member of SMEO. Sociedad Mexicana de Oncología. 

University teacher at Universidad Anahuac of Medicine since 2020.